315 related articles for article (PubMed ID: 22664222)
21. Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica.
Arguedas A; Abdelnour A; Soley C; Jimenez E; Jimenez AL; Ramcharran D; Porat N; Dagan R; Gray S; Rodgers GL
Vaccine; 2012 Mar; 30(13):2342-8. PubMed ID: 22300725
[TBL] [Abstract][Full Text] [Related]
22. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
[TBL] [Abstract][Full Text] [Related]
23. [Effect of the Pneumococcal Conjugated Vaccines on Burden of all Cause Pneumonia, Bacterial Pneumonia and Empyema in Children].
Tsakir C; Özdemir H; Arga G; Konca HK; Çakmak Taşkın E; Öcal D; Çiftçi E; İnce E
Mikrobiyol Bul; 2022 Jul; 56(3):466-479. PubMed ID: 35960238
[TBL] [Abstract][Full Text] [Related]
24. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
Grijalva CG; Nuorti JP; Arbogast PG; Martin SW; Edwards KM; Griffin MR
Lancet; 2007 Apr; 369(9568):1179-86. PubMed ID: 17416262
[TBL] [Abstract][Full Text] [Related]
25. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
[TBL] [Abstract][Full Text] [Related]
26. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil.
Andrade AL; Oliveira R; Vieira MA; Minamisava R; Pessoa V; Brandileone MC; Alves SL; Alfieri F; Pagliarini R; Moraes JC; Gray S; Rodgers GL
Vaccine; 2012 Feb; 30(10):1901-9. PubMed ID: 22178522
[TBL] [Abstract][Full Text] [Related]
27. Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine.
Antachopoulos C; Tsolia MN; Tzanakaki G; Xirogianni A; Dedousi O; Markou G; Zografou SM; Eliades A; Kirvassilis F; Kesanopoulos K; Roilides E
Pediatr Infect Dis J; 2014 Jan; 33(1):81-3. PubMed ID: 24172850
[TBL] [Abstract][Full Text] [Related]
28. Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia.
Cremers AJ; Meis JF; Walraven G; Jongh CE; Ferwerda G; Hermans PW
Vaccine; 2014 Jun; 32(31):3989-94. PubMed ID: 24814555
[TBL] [Abstract][Full Text] [Related]
29. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
31. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
32. Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?
Boccalini S; Varone O; Chellini M; Pieri L; Sala A; Berardi C; Bonanni P; Bechini A
Hum Vaccin Immunother; 2017 Feb; 13(2):428-434. PubMed ID: 27925848
[TBL] [Abstract][Full Text] [Related]
33. Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules.
Lee HY; Hsieh YC; Liu CC; Huang YC; Chang KY; Chi H; Chang LY; Huang YC; Huang LM;
J Microbiol Immunol Infect; 2018 Apr; 51(2):199-206. PubMed ID: 29021105
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
[TBL] [Abstract][Full Text] [Related]
35. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan.
Naito S; Tanaka J; Nagashima K; Chang B; Hishiki H; Takahashi Y; Oikawa J; Nagasawa K; Shimojo N; Ishiwada N
Epidemiol Infect; 2016 Feb; 144(3):494-506. PubMed ID: 26122538
[TBL] [Abstract][Full Text] [Related]
36. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
[TBL] [Abstract][Full Text] [Related]
37. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
[TBL] [Abstract][Full Text] [Related]
38. Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine.
Goldbart AD; Leibovitz E; Porat N; Givon-Lavi N; Drukmann I; Tal A; Greenberg D
Scand J Infect Dis; 2009; 41(3):182-7. PubMed ID: 19117244
[TBL] [Abstract][Full Text] [Related]
39. Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010.
Liesenborghs L; Verhaegen J; Peetermans WE; Vandeven J; Flamaing J
Vaccine; 2013 Mar; 31(11):1529-34. PubMed ID: 23261044
[TBL] [Abstract][Full Text] [Related]
40. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.
Elberse KE; van der Heide HG; Witteveen S; van de Pol I; Schot CS; van der Ende A; Berbers GA; Schouls LM
Vaccine; 2012 Dec; 30(52):7644-51. PubMed ID: 22521844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
